SCHEMBL24278685

SCHEMBL24278685

CC(C)C12CCC(C)(c3ccccc31)C(OC(=O)c1ccccc1)C2OC(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ GAA P10253 1/20 0.42
▸ CHRNA7 P36544 2/20 0.39
▸ HTR3E A5X5Y0 1/20 0.39
▸ HTR3B O95264 1/20 0.39
▸ HTR3A P46098 1/20 0.39
▸ HTR3D Q70Z44 1/20 0.39
▸ HTR3C Q8WXA8 1/20 0.39
▸ TSHR P16473 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ SCN1A P35498 1/20 0.38
▸ SCN2A Q99250 1/20 0.38
▸ SCN3A Q9NY46 1/20 0.38
▸ TRPM8 Q7Z2W7 1/20 0.37
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ CHRM2 P08172 1/20 0.36
▸ CHRM4 P08173 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27053559 1.00 LMNA (0.44) LMNATDP1GAACHRNA7HTR3E
SCHEMBL25755711 1.00 LMNA (0.44) LMNATDP1GAACHRNA7HTR3E
SCHEMBL27052041 0.84 GAA (0.44) LMNATDP1GAACHRNA7HTR3E
SCHEMBL27052038 0.80 GAA (0.51) LMNATDP1GAACHRNA7HTR3E
SCHEMBL27053179 0.74 GAA (0.44) LMNATDP1GAACHRNA7HTR3E
SCHEMBL27134059 0.74 GAA (0.48) LMNATDP1GAACHRNA7HTR3E
SCHEMBL27134058 0.72 GAA (0.55) LMNATDP1GAACHRNA7HTR3E
SCHEMBL27061699 0.72 GAA (0.51) LMNATDP1GAACHRNA7HTR3E
SCHEMBL27105330 0.72 GAA (0.51) LMNATDP1GAACHRNA7HTR3E
SCHEMBL27053178 0.72 GAA (0.51) LMNATDP1GAACHRNA7HTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067763-A1 SOLID TITANIUM CATALYST COMPONENT, OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION METHOD, AND PROPYLENE POLYMER MITSUI CHEMICALS, INC. (JP) 2024-02-29 — — US disclosed
US-20240025838-A1 ESTER COMPOUND MITSUI CHEMICALS, INC. (JP) 2024-01-25 — — US disclosed
EP-4206182-A1 ESTER COMPOUND Mitsui Chemicals, Inc. (JP) 2023-07-05 — — EP disclosed
WO-2022045231-A1 ESTER COMPOUND 三井化学株式会社 2022-03-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240025838-A1 ESTER COMPOUND NR1H3, CYP4A11, H1-4 LMNA 2172/4885TDP1 4445/4885GAA 4343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback